GRI Bio (GRI) Treasury Shares (2021 - 2022)

GRI Bio (GRI) posted quarterly Treasury Shares of $7816.0 for Q3 2022, little changed quarter-over-quarter from $7816.0 in Q2 2022.

GRI Bio (GRI) Treasury Shares (2021 - 2022) Analysis & Trends

GRI Bio's Treasury Shares history runs 2 years deep, the most recent figure standing at $7816.0 for Q3 2022.

In Q3 2022, Treasury Shares changed N/A year-over-year to $7816.0; the TTM figure through Sep 2022 stood at $7816.0 (changed N/A YoY), while the FY2021 annual figure was $1116.0, changed N/A from the prior year.
Treasury Shares for Q3 2022 stood at $7816.0, roughly flat from $7816.0 in the prior quarter.
The five-year high for Treasury Shares was $7816.0 in Q1 2022, with the low at $1116.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	GRI Bio	3.01 Mn	3.01 Mn	-	-

Download Data